askbio
PrivateLast Round
M&A
Oct 26, 2020
Last Round Size
$2B
Est. Valuation
$4B
Total Funding Raised
$2.24B
Company Overview
AskBio is a biopharmaceutical company specializing in the development and manufacturing of Adeno-Associated Virus (AAV) gene therapy therapeutics for rare and generally untreatable genetic disorders.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
askbio Comparables
Compare askbio with similar companies based on industry and business-model similarity.
askbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 26, 2020 | ||||
| Grant | Sep 2, 2020 | ||||
| Series A | Apr 11, 2019 | ||||
| Grant | Jul 22, 2004 |
askbio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about askbio's valuation, stock price, and market status.